In the past decade, we have seen massive advances in the amount of data we routinely generate and collate in pretty much everything we do, as well as our ability to use technology to analyse and understand it. The intersection of these trends is what we now call “big data” and it is helping businesses across various industries to become more efficient and more productive.
Healthcare is no different. Beyond reducing cost on wasted overhead and improving profits, big data in healthcare is being used to predict epidemics, cure disease, improve quality of life and avoid preventable deaths.
Holmusk, a Singaporean digital health start-up, is one of such companies that are using data to solve complex problems in healthcare.
In early April, they announced they would be embarking on a three-year partnership with the National Heart Centre Singapore (NHCS) to improve care for heart failure and coronary artery disease using big data analytics to build better predictive models that can be validated for use in the treatment and prevention of cardiovascular disease in Singapore.
Supported by the Singapore Economic Development Board (EDB), Holmusk will collaborate with NHCS to analyse aggregated data from the Singapore Cardiac Longitudinal Outcomes Database (SingCLOUD) to drive insights and build effective tools for clinical decision support.
“Innovations in healthcare is happening at a rapid pace globally. Precision medicine is the future of healthcare and big data analytics will play a significant role to improve clinical outcomes as well as operational and financial outcomes,” said Nawal Roy, CEO and founder of Holmusk.
He explained that Holmusk is focused on bringing cutting-edge analytic practices that facilitate early detection of cardiovascular disease and early intervention to engage patients before they become chronic. “This initiative could turn into a nationwide effort to optimise efficiency and improve clinical outcomes for cardiovascular patients in Singapore, while providing a gold standard of reference for the APAC region.” Nawal said.
In Singapore, an estimated 16 people die from cardiovascular disease every day. In 2015, the disease accounted for 29.6% of all deaths in the city-state, meaning that nearly 1 in 3 deaths here were due to heart disease or stroke.
Associate Professor Yeo Khung Keong, a Senior Consultant at NHCS said that the aim of the collaboration was to be able to track clinical outcomes and design targeted intervention strategies that improve care in patients with heart failure or coronary artery disease.
Ms. Ho Weng Si, Director of the Biomedical Sciences division at EDB, added: “Healthcare is a growing and evolving sector where value creation is driven by evidence-backed innovation, with a clear focus on better patient outcomes. This partnership is a promising example of local private and public sector collaboration to create data-driven healthcare solutions which will improve healthcare in Singapore and the region.”
The partnership is a three year-long project that will run through to 2019.